Fusion event
HBV-chr21 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAG| |GTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGT
End
15394917/14022596 (Hg38)
Nearest miRNA
hsa-mir-10396a/Upstream/298322; hsa-let-7c/Downstream/2516493;
Upstream sequence
CAGACTTTTCAGAATTCCCCAAAGATACTGAAACTCAGACCCATTCTGACCCCACCCCAAAAAGTATCATAAATGGAATCTGGGAGCCATTCAGAGTCTC
Downstream sequence
CAGCCTCCTCTTTGGTGAAAATGGACTTGGACCTAAAAAGGCACCCCACTGTCCACAAGGACACAAATTCAGATGCTGAGCACTGGCCTCCTGCCTTCCG
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.